- What is NGT3's primary investment focus?
- NGT3 primarily invests in early-stage technology-based startup companies with a social agenda, focusing on innovative medical devices and life sciences. They also encourage Arab and Jewish entrepreneurship.
- What investment stages does NGT3 target?
- NGT3 targets Seed and Pre-Seed investment stages.
- Can you name some of NGT3's portfolio companies?
- NGT3's portfolio includes companies such as Nurami Medical, which raised $43.65M for modernizing soft tissue repair, and Virility Medical, which raised $21M for a skin patch for the treatment of premature ejaculation.
- What is NGT3's geographic focus for investments?
- NGT3 is rooted in Nazareth, Israel, and focuses on new opportunities while fostering a social agenda of inclusion and multicultural collaboration within the region.
- Who are the key managing partners at NGT3?
- The key managing partners at NGT3 are Zohar Gendler, CEO & Managing Partner, and Nizar Mishael, CFO & Managing Partner.
- What is the most recent investment round identified for a NGT3 portfolio company?
- In August 2021, NGT3 participated in an investment round for a portfolio company.
- What is NGT3's historical background?
- NGT3 is the next generation of NGT, which operated as a technological incubator since 2002. Its operation continues today under the name NGT HealthCare II.
- What is NGT3's approach to investment beyond financial returns?
- NGT3 focuses on a triple bottom line: developing and creating value for cutting-edge medical technologies, providing high financial returns for its partners and investors, and fostering a social agenda of inclusion and multicultural collaboration.
